Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 20 February 2024 28 February 2025 28 February 2025 15506477 Mr Stuart Roche iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15506477 2024-02-19 15506477 2025-02-28 15506477 2024-02-20 2025-02-28 15506477 frs-core:CurrentFinancialInstruments 2025-02-28 15506477 frs-bus:PrivateLimitedCompanyLtd 2024-02-20 2025-02-28 15506477 frs-bus:FilletedAccounts 2024-02-20 2025-02-28 15506477 frs-bus:Micro-entities 2024-02-20 2025-02-28 15506477 frs-bus:AuditExempt-NoAccountantsReport 2024-02-20 2025-02-28 15506477 frs-bus:Director1 2024-02-20 2025-02-28
Registered number: 15506477
Dift Ltd
Unaudited Financial Statements
For the Period 20 February 2024 to 28 February 2025
Balance Sheet
Registered number: 15506477
28 February 2025
£
Current assets 47,855
Creditors: Amounts Falling Due Within One Year (21,862 )
NET CURRENT ASSETS 25,993
TOTAL ASSETS LESS CURRENT LIABILITIES 25,993
NET ASSETS 25,993
CAPITAL AND RESERVES 25,993

Notes

1. General Information
Dift Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15506477 . The registered office is 9 Thetford Drive, Leyland, Lancashire, PR25 5PG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Stuart Roche
Director
22/04/2025